-
Kyverna’s CAR-T Therapy Succeeds in Stiff Person Syndrome Trial and Targets First Autoimmune Approval
Dec 15 2025 -
Link Cell Therapies Launches with $60M Series A to Advance Logic-Gated CAR-T for Solid Tumors
Dec 15 2025 -
Tenaya’s AAV Gene Therapy TN-401 Shows Early Safety and Arrhythmia Reduction in ARVC Patients
Dec 11 2025 -
Tetraneuron Secures Funding to Advance First-in-Class AAV Gene Therapy for Alzheimer’s disease
Dec 11 2025 -
FDA Approves First LVV-based Gene Therapy for Wiskott-Aldrich Syndrome
Dec 10 2025 -
Diakonos Oncology Secures $7M CPRIT Grant to Advance Personalized Dendritic Cell Vaccine for Refractory Melanoma
Dec 10 2025 -
Strategic Focus Drives Evolution in Cell and Gene Therapy Funding Landscape
Dec 10 2025 -
FDA Set to Require Randomized Trials and Superiority Data for Full CAR T Approval
Dec 09 2025 -
Japan Grants Pioneering AAV Gene Therapy Designations to AskBio for Parkinson’s and Heart Failure Programs
Dec 09 2025